Authorized Generic

Quote
anonymous said:
What did the poster get wrong? After reading it and reviewing the pricing implications along with the upside for the PBM, sticking with the branded products seems like the fiscally responsible move.
Click to expand...
The pricing implications are not necessarily correct. All contracts are different and pharmacies profit more when dispensing generic versus brand drugs. The OP makes it sound much simpler than it is.
It is not financially responsible to have the patient pay more, and the government certainly is not going to.
 






anonymous said:
The pricing implications are not necessarily correct. All contracts are different and pharmacies profit more when dispensing generic versus brand drugs. The OP makes it sound much simpler than it is.
It is not financially responsible to have the patient pay more, and the government certainly is not going to.
Click to expand...

doesn’t matter what the pharmacy pays for the brand or the AG. What matters ultimately is whether the plan covers the medication. And what plan will cover something with a 35% discount vs a 60-70% rebate?

if I offer you a $100 item at a 35% discount, you pay $65. If I take that same $100 product and give you a 60% rebate, you only pay $40.

which is the better deal for you?
 






anonymous said:
doesn’t matter what the pharmacy pays for the brand or the AG. What matters ultimately is whether the plan covers the medication. And what plan will cover something with a 35% discount vs a 60-70% rebate?

if I offer you a $100 item at a 35% discount, you pay $65. If I take that same $100 product and give you a 60% rebate, you only pay $40.

which is the better deal for you?
Click to expand...
Ask Medicare
 
























anonymous said:
doesn’t matter what the pharmacy pays for the brand or the AG. What matters ultimately is whether the plan covers the medication. And what plan will cover something with a 35% discount vs a 60-70% rebate?

if I offer you a $100 item at a 35% discount, you pay $65. If I take that same $100 product and give you a 60% rebate, you only pay $40.

which is the better deal for you?
Click to expand...

Something tells me there’s more to it than this basic math or why would they even launch an AG
 






anonymous said:
doesn’t matter what the pharmacy pays for the brand or the AG. What matters ultimately is whether the plan covers the medication. And what plan will cover something with a 35% discount vs a 60-70% rebate?

if I offer you a $100 item at a 35% discount, you pay $65. If I take that same $100 product and give you a 60% rebate, you only pay $40.

which is the better deal for you?[/QUOT

Can you name a few generics that did not cannibalize their branded equivalents?
Then we may believe this theory.
Click to expand...
 




































anonymous said:
Can you name a few generics that did not cannibalize their branded equivalents?
Then we may believe this theory.
Click to expand...

this is NOT a typical generic. It is an authorized generic. This is AZ/Prasco selling their own ‘generic’.
The patent on Farxiga goes into 2026. At that point, once they hit LOE and there are multiple generic manufacturers, then the category could be in trouble.
 






anonymous said:
this is NOT a typical generic. It is an authorized generic. This is AZ/Prasco selling their own ‘generic’.
The patent on Farxiga goes into 2026. At that point, once they hit LOE and there are multiple generic manufacturers, then the category could be in trouble.
Click to expand...

Then why is BI leadership in the midst of a fire drill trying to figure it out?
 




































Top Bottom
Back
Quote